NCT07024784
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07024784
Title A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: senior | adult
Covered Countries ISR

Facility Status City State Zip Country Details
The Chaim Sheba Medical Center /ID# 275997 RECRUITING Ramat Gan Tel Aviv 5265601 Israel Details
Tel Aviv Sourasky Medical Center /ID# 275852 RECRUITING Tel Aviv Tel Aviv 6423906 Israel Details
Rambam Health Care Campus /ID# 276004 RECRUITING Haifa 3525408 Israel Details
Shaare Zedek Medical Center /ID# 275854 RECRUITING Jerusalem 9103102 Israel Details
Hyogo Cancer Center /ID# 276940 RECRUITING Akashi-shi Hyōgo 673-8558 Japan Details
National Cancer Center Hospital /ID# 276715 RECRUITING Chuo-Ku Tokyo 104-0045 Japan Details
The Cancer Institute Hospital Of JFCR /ID# 276711 RECRUITING Koto-ku Tokyo 135-8550 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field